06-08-2026 21:49 via drugs.com

FDA Approves First Drug for Full Range of Narcolepsy Symptoms

THURSDAY, Aug. 6, 2026-- The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.Orzeyful marks the first medicine approval for the full range of symptoms associated with...
Read more »

Pharmaceutical news



Type 2 Diabetes Linked to Worse Menopausal Symptoms
Adult Children of Divorced, Unmarried Parents Face More Mental Health Issues
FDA Reverses Course, Approves First mRNA Flu Shot
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD
Breathing Interventions May Curb Cravings With Substance Use
Study IDs Gaps in Hereditary Breast Cancer Risk Assessment Before Gender-Affirming Mastectomy
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis
Wildfires Now Top Source of Unhealthy Air for Pregnant Women in U.S.
Therapy Dogs Aid Stroke Rehab
Can Yoga Calm A Grumpy Gut?
Short-Term Vegan Diet Linked To Lower Inflammation And Aging
Review Finds Little Proof IVF Embryo Transfer Tricks Boost Success
Wildfire Smoke An Increasing Hazard To U.S. Pregnancies, Study Says
Medicaid Work Rule Leaves Homeless People In The Cold
Desktop versie